Blood Sugar Monitoring in Critically Ill Patients: Risks & Management

Critically ill patients face high risk of both hyperglycemia and hypoglycemia, each carrying serious consequences. Vigilant glucose monitoring is essential.

Hyperglycemia in Critical Illness

Causes:

  • Stress response: cortisol, catecholamines, glucagon ↑ → gluconeogenesis, insulin resistance
  • Exogenous glucose: IV fluids, nutrition, medications
  • Medication effects: steroids, vasopressors

Consequences: Infection risk ↑, wound healing delayed, organ dysfunction, mortality ↑

Hypoglycemia in Critical Illness

Causes:

  • Impaired oral intake
  • Insulin/insulin secretagogues
  • Liver/kidney dysfunction impairing gluconeogenesis
  • Sepsis, adrenal insufficiency

Consequences: Seizures, coma, neurological injury, death

Evidence-Based Targets & Monitoring

  • Target range: 140–180 mg/dL (per ADA/SCCM guidelines)
  • Frequency: q1–2h for high-risk (insulin infusion, unstable); q4h for stable
  • Methods: Arterial line (gold standard), capillary (point-of-care), continuous glucose monitoring (emerging)
  • Who monitors: ICU nurses, physicians, pharmacists (protocol-driven)

Protocolized insulin therapy with frequent monitoring reduces both hyper- and hypoglycemia, improving outcomes.

Diabetes - Related Articles